MCQOPTIONS
Saved Bookmarks
| 1. |
In November 2020, which of the following has launched a new large-scale late-stage trial to test a two-dose regimen of its experimental COVID-19 vaccine? |
| A. | Pfizer |
| B. | AstraZeneca |
| C. | Johnson & Johnson |
| D. | Procter and Gamble |
| E. | Gilead Sciences |
| Answer» D. Procter and Gamble | |